British Pharmacopoeia 2025 Single-user Online Subscription Edition

Product Description

British Pharmacopoeia (BP) 2025: Comprehensive Standards for Pharmaceutical Products in the UK

The BP 2025 Single-user Online Subscription
The Single-user Online Subscription includes:

• A single-user online licence* valid from 1 August 2024 to 31 March 2026

The British Pharmacopoeia (BP) is an annually updated, authoritative collection of standards governing pharmaceutical substances and medicinal products in the UK. With approximately 4,000 legally enforced monographs outlined by the Human Medicines Regulations 2012, compliance is mandatory for medicinal products and active pharmaceutical ingredients distributed in the UK.

Key Features of BP 2024:
Legal Effectiveness: The BP 2024, effective from January 1, 2024, supersedes the BP 2023. It incorporates new monographs from both the BP and the European Pharmacopoeia (Ph. Eur.) alongside a substantial number of revised monographs.
European and Global Relevance: The BP includes all monographs and requirements of the Ph. Eur., positioning it as a comprehensive set of standards applicable not only in the UK but across Europe and beyond.

Other formats are available to ensure users get the best value access to the information they need

*Note: Single-user licenses are granted to one designated holder. Multi-user licenses are available.